Texas Biotechnology's Argatroban approved in Canada

TXBI received Canadian marketing approval for its Argatroban direct thrombin inhibitor as an anticoagulant in patients with heparin-induced thrombocytopenia (HIT) syndrome. GlaxoSmithKline (GSK; LSE:G...